WiersingaWJRhodesAChengACPeacockSJ, et al.
Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA2020;
324: 782.
2.
WölfelRCormanVMGuggemosW, et al.
Virological assessment of hospitalized patients with COVID-2019.Nature2020;
581: 465–469.
3.
RichardsonSHirschJSNarasimhanM, et al.; the Northwell COVID-19 Research Consortium.
The Northwell COVID-19 research consortium. presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA2020;
323: 2052–2059.
4.
WangCLiWDrabekD, et al.
A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun2020;
11: 2251.
5.
BrouwerPJMCanielsTGvan der StratenK, et al.
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.Science2020;
369: 643–650.
